🇺🇸 Rifadin in United States

5,208 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Interaction — 1,015 reports (19.49%)
  2. Pyrexia — 843 reports (16.19%)
  3. Drug Reaction With Eosinophilia And Systemic Symptoms — 570 reports (10.94%)
  4. Drug Ineffective — 520 reports (9.98%)
  5. Drug-Induced Liver Injury — 449 reports (8.62%)
  6. Vomiting — 422 reports (8.1%)
  7. Nausea — 365 reports (7.01%)
  8. Acute Kidney Injury — 353 reports (6.78%)
  9. Condition Aggravated — 343 reports (6.59%)
  10. Jaundice — 328 reports (6.3%)

Source database →

Rifadin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Rifadin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rifadin in United States?

Sanofi Aventis Us is the originator. The local marketing authorisation holder may differ — check the official source linked above.